Fwd: NIAID Funding Newsletter, July 16, 2014

---------- Forwarded message ----------
From: National Institute of Allergy and Infectious Diseases (NIAID) <niaid@service.govdelivery.com>
Date: Wed, Jul 16, 2014 at 1:18 PM
Subject: NIAID Funding Newsletter, July 16, 2014
To: iammejtm@gmail.com

Leading Research to Understand, Treat, and Prevent Infectious, Immunologic, and Allergic Diseases          Visit us on the Web You are subscribed to the "NIAID Funding Newsletter" interest category. Adjust your subscriptions at Quick Subscribe. July 16, 2014, NIAID Funding Newsletter Read this full issue online at http://www.niaid.nih.gov/researchfunding/newsletter/2014/Pages/0716.aspx Feature Articles Addressing Unforeseen Administrative Issues After Submission Last month we reviewed When NIH Accepts Late Submissions, but what about when you submit your application on time and you need to add an update before peer review? Read the full article. Opportunities and Resources An Opportunity to Participate in Immune-Related Genomics Consortium Formed in 2005, the HLA and KIR Region Genomics in Immune-Mediated Diseases Consortium, a cooperative research group, has been dedicated to defining associations between 1) polymorphisms in the human leukocyte antigen (HLA) and natural killer cell immunoglobulin-like receptor (KIR) genomic regions and 2) transplantation outcome or susceptibility or resistance to immune-mediated diseases. Read the full article. Now's Your Chance to Join Radiation Countermeasures Consortium NIAID is once again soliciting applications from those interested in joining the Centers for Medical Countermeasures Against Radiation Consortium. Read the full article. Testing Immune Tolerance in Organ Donation The Immune Tolerance Network (ITN), a clinical research consortium sponsored by NIAID, is seeking proposals for clinical tolerance clinical trials in transplantation using solid organs or islets from recently deceased donors. Read the full article. Immune-Based Antiviral Products Solicitation On the Way Researchers working on immune-based antiviral products to combat HIV-1 should stay on the lookout for a new opportunity from NIAID's Division of AIDS (DAIDS), set to come out later this month. Read the full article. In The News K99/R00 Applicants: Be Aware of Modified Instructions Investigators planning to submit an application for the NIH Pathway to Independence Award (K99/R00), take note: NIH recently modified budget instructions by removing some information, including how much to enter for total and indirect costs. Read the full article. News Briefs New Web Tool Displays Timeline of Key Policy Changes Administrative Cores Now Optional in Parent P01 Annual Requirement Dropped for NRSA Fellows at Foreign and Federal Institutions Annotated Forms Available to Guide Small Business Applicants Advice Corner Big Grant Applications Need Our Approval If your grant application requests $500,000 or more in direct costs in any year, get NIAID's approval well before you submit. Without our approval, NIH's Center for Scientific Review will reject your application without a review. Read the full article. Reader Questions Is there a limit to the number of summer months that can be listed on an NIH budget proposal? How does the new submission policy extend to renewal applications? New Funding Opportunities PA-14-278, Ethical, Legal, and Social Implications (ELSI) of Genomic Research Regular Research Program (R21) PA-14-277, Ethical, Legal, and Social Implications (ELSI) of Genomic Research Regular Research Program (R03) PA-14-276, Ethical, Legal, and Social Implications (ELSI) of Genomic Research Regular Research Program (R01) RFA-AI-14-015, Development of Novel Therapeutics for Select Anaerobic Protozoa RFA-AI-14-049, NIAID SBIR-Technology Transfer Direct Phase II (SBIR-TT) RFA-AI-14-057, U.S.-China Program for Research Toward a Cure for HIV/AIDS See other announcements at NIAID Funding Opportunities List. Send suggestions or comments to deaweb@niaid.nih.gov . Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID). This email was sent to iammejtm@gmail.com using GovDelivery, on behalf of: National Institute of Allergy and Infectious Diseases · 6610 Rockledge Drive · Bethesda, MD 20892 · 866-284-4107

--
Jeremy Tobias Matthews